(IN BRIEF) WACKER has launched a new Contract Research Services platform designed to support biotech and biopharma companies developing nucleic acid-based medicines, including RNA therapies, plasmid DNA technologies and lipid nanoparticle formulations. Operating from the company’s Biotechnology Center in Munich, … Read the full press release
Posted in Business, Chemicals, Economy, Financial, Germany, Industrial, Investment, Management, Marketing, Pharma & Biotech, Science, Technology
Tagged advanced therapeutics, biopharma, biotechnology, biotechnology innovation, biotechnology research, circular RNA, clinical manufacturing, Contract Research Services, crs, drug development, gene therapy, GMP manufacturing, lipid nanoparticles, LNPs, mRNA, Munich, nucleic acid medicines, pDNA, pharmaceutical industry, plasmid DNA, PLASMITEC®, RNA engineering, RNA therapeutics, saRNA, self-amplifying RNA, SRTD Biotech GmbH, vaccine development, WACKER, Wacker Biotech, WACKER expands advanced therapeutics capabilities with integrated Contract Research Services offering, WACKER expands biotechnology services with new Contract Research Services platform for nucleic acid medicines, WACKER launches new biotechnology research platform for RNA and nucleic acid therapeutic development, WACKER strengthens global biotechnology services with scalable nucleic acid development solutions
(IN BRIEF) WACKER and Gearbox Biosciences have launched a partnership to co-develop advanced, antibiotic-free pDNA manufacturing techniques aimed at improving scalability, efficiency, and cost-effectiveness. Leveraging WACKER’s GMP biologics know-how and Gearbox’s Pop-Out-Plasmid® technology, the project will focus on streamlining workflows … Read the full press release
Posted in Business, Chemicals, Estonia, Financial, Germany, Government, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged advanced therapies, antibiotic resistance, antibiotic-free manufacturing, biomanufacturing, collaboration, cost-effectiveness, efficiency, ESETEC®, GEA, Gearbox Biosciences, GMP biologics, microbial fermentation, Munich Biotechnology Center, partnership, pDNA, plasmid DNA, PLASMITEC®, Pop-Out-Plasmid®, San Diego, Scalability, WACKER
(PRESS RELEASE) MUNICH/ HALLE, PLANKSTADT, 11-Apr-2022 — /EuropaWire/ — WACKER Group (ETR: WCH), a German multinational chemical company, and CordenPharma, the global pharmaceutical service & manufacturing platform of International Chemical Investors Group (ICIG), have announced that their joint bid to … Read the full press release
Posted in Chemicals, Germany, Government, Healthcare, News, Pharma & Biotech, Technology
Tagged biotech site, Christian Hartel, CordenPharma, coronavirus pandemic, lipid nanoparticles, LNP, messenger ribonucleic acid, Michael Quirmbach, mRNA, pDNA, plasmid DNA, Susanne Leonhartsberger, vaccine, WACKER, Weinberg Campus
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?